Following the statutory WHO nomination deadline for the next Director-General, six candidates have now been publicly declared on the agency’s prospective candidate page. While oncologist Dr Gevorg Tamamyan has been proposed in a cross-regional nomination by Botswana, sources with knowledge of the process said Gavi CEO Dr Sania Nishtar was reportedly not nominated by Pakistan. Additional nominees, however, may remain hidden behind a month-long procedural “black box.”

As the submission window for the next Director-General of the World Health Organization (WHO) closed on Thursday (24 September), the high-stakes political race officially shifted to an active global campaign trail. The candidate pool currently stands at six publicly known contenders following Tamamyan’s recent entry.

However, the global public may not learn the complete, official candidate roster until November. Under WHO election protocols, nominating governments can request early public acknowledgement of their nominee as a “prospective candidate” on the agency’s website. But if a government chooses not to make such a request, the candidate’s filing will remain confidential until November, the agency said.

“The names of candidates and the proposals received will be published on the WHO’s website after the closure of the last Regional Committee session held this year, expected at the beginning of November 2026,” WHO told Health Policy Watch in an official statement.

While intended to ensure uniform, translated candidate dispatches to all Member States, the rule creates a two-tier transparency system. States opting for confidentiality can keep filings sealed until November, leaving unannounced contenders to campaign shielded from public scrutiny.

Ahead of the official November unveiling, here are the six publicly declared contenders currently vying to lead the world’s premier health agency, listed from the first entry to the most recent.

1. The inside reformer: Dr Hans Henri P. Kluge (Belgium)

Kluge, the first contender nominated on 21 August, has served as WHO Regional Director for Europe (on leave for his campaign) since 2020 following a WHO career and frontline MSF humanitarian work. Presenting himself as the agency’s “biggest advocate, yet also its most candid critic”, Kluge promises to devolve power from Geneva to country offices and make Primary Health Care (PHC) his signature delivery platform.

“My vision is to rebuild WHO, together with the Member States, into a 21st-century organisation that better serves all countries and their people,” Kluge emphasized in his manifesto. “WHO’s legacy, scientific authority, and convening power are unmatched, but the organization is often overstretched, under-focused, and overly bureaucratic – and that must change.”

2. The institutional regionalist: Dr Hanan H. Balkhy (Saudi Arabia)

Balkhy, put forward on 24 August by Saudi Arabia, is a paediatric infectious disease specialist, former WHO Assistant Director-General for AMR, and EMRO Regional Director (on leave for her campaign). Her platform focuses on regional self-reliance, local vaccine manufacturing, One Health biosecurity, and shifting WHO’s operational weight directly from Geneva HQ to country and regional offices.

“My running title for this campaign is a WHO the world can count on: built on trust, driven by impact, and measured by value,” Balkhy declared at an invite-only panel hosted by Concordia on the sidelines of the UN General Assembly in New York on Thursday. Addressing budget pressures and institutional delivery, she added: “How do we use our money better? One of the first things I would start with is identifying country by country their country-driven priorities … If we improve our performance, we will use less funding and use it much better.”

3. The middle-power broker: Dr Hanan Mohamed Al Kuwari (Qatar)

Nominated on 26 August, former Minister of Public Health and long-serving Managing Director of Hamad Medical Corporation, Al Kuwari positions herself as an executive system manager and pragmatic mediator. Serving as Vice-Chair of Pandemic Agreement negotiations, she leverages Qatar’s middle-power diplomacy to advance binding pathogen access and benefit-sharing (PABS) equity.

“We already know how to prevent and treat many of the diseases that continue to affect millions of people. The challenge is making sure that knowledge translates into concrete actions resulting in better health outcomes everywhere,” she wrote in her candidacy announcement on LinkedIn. “That requires a WHO that countries trust, that can act independently, that is sustainably financed, and, above all, that delivers meaningful results for people and communities.”

4. The corporate outsider: Budi Gunadi Sadikin (Indonesia)

Indonesia’s Health Minister, nominated on 31 August, represents an unconventional candidacy from outside clinical medicine. A nuclear physicist and former CEO of Indonesia’s largest bank, Sadikin advocates for economic reform, Global South vaccine sovereignty, and leveraging development bank capital to bridge WHO’s funding deficits.

“As an ex-banker, I know the world is ample of liquidity and money, so there is no reason why we don’t have enough money,” Sadikin stated at the Concordia debate on Thursday in New York.

Addressing how WHO can overcome budget deficits and eliminate donor earmarking, he added: “Number one, [WHO] should refocus back to its core mandate: setting norms and standards based on science,” Sadikin said. “And number two, WHO has a very powerful convening power … to build bridges between Member States, multilateral development banks, philanthropists, and global health institutions. As long as we can build trust and credibility, money will come, and earmarking will be gone.”

5. The primary prevention advocate: Dr María Neira (Spain)

Spain’s last-minute nomination on 24 September introduces a prominent advocate for planetary health and primary prevention to the race for WHO’s top job. Having spent two decades directing WHO’s Department of Environment, Climate Change and Health, Neira combines field emergency care with Geneva executive tenure. Her platform calls for a “massive shift towards primary prevention” and using WHO’s normative authority to direct global capital toward environmental health drivers.

“I believe deeply in WHO. I know its people, its strengths, and how much the world asks of it. I also know that an organization can move mountains when it brings science, countries and people together around a shared purpose: better health for everyone,” she wrote in her nomination announcement on LinkedIn. “I begin this journey as I began my work in public health: with curiosity, determination, and the conviction that every life deserves our attention.”

Oncology advocate & crisis specialist: Dr Gevorg Tamamyan (Botswana)

Armenian paediatric oncologist Dr Gevorg Tamamyan enters the race as a geopolitical standout: he is the sole cross-regional nomination in the field and the only candidate proposed by an AFRO Member State, following his formal submission by Botswana.

Tamamyan is Professor and Chairman of Pediatric Oncology and Hematology at Yerevan State Medical University, CEO of the Immune Oncology Research Institute, and President of the POEM Group – a cooperative network spanning 110 cancer centres across 28 countries. He also serves as Editor-in-Chief of OncoDaily and Chairman of the Board of the Institute of Cancer and Crisis. His clinical background is further supported by fellowships and advanced training at MD Anderson, St. Jude, Harvard, and Vienna.

While Tamamyan has not yet published an official election manifesto or campaign platform, his background as a clinician introduces a distinct profile centred on non-communicable disease (NCD) burdens, paediatric health equity, and healthcare delivery in fragile, conflict- and crisis-affected zones.

Notable absences and unverified candidacies

Despite early speculation across global health circles and her prominent 2017 candidacy for the top post, sources close to the matter confirm that Dr Sania Nishtar, currently CEO of Gavi, the Vaccine Alliance, is not running in this election cycle. She joins other high-profile figures who have previously ruled out bids, including PAHO Regional Director Dr Jarbas Barbosa and former WHO Chief Scientist Dr Jeremy Farrar.

Health Policy Watch reached out to Gavi for official confirmation prior to publication but did not receive a response.

Questions also surround South Korean lawmaker and digital health advocate Dr Jiho Cha, as he appeared on stage at Thursday’s Concordia panel in New York alongside Balkhy and Sadikin and was announced as one of the candidates. He presented his election manifesto, “Renewing the Promise, Delivering the Future: Health for All,” centred on AI public governance and climate resilience. However, his formal nomination status could not yet be confirmed.

Under WHO election protocols, candidacies must be formally lodged by a proposing Member State. The Government of the Republic of Korea did not respond to requests for comment, while the WHO Secretariat declined to disclose information regarding individual filings ahead of the official announcement in November.

Geopolitical fault lines and financial shortfalls

Whoever ultimately wins the election will have to steer WHO through an unprecedented financial squeeze and deep geopolitical fragmentation.

This fiscal shock has accelerated calls to reform the global health architecture away from traditional donor dependency. Global South platforms such as the Accra Reset initiative urge a systemic transition toward domestic health sovereignty, regional manufacturing, and sustainable local financing models.

However, while political leaders champion this pivot, operationalizing it remains extremely challenging. Overburdened by mounting debt service that sees 32 African nations spend more on external debt than healthcare, most low-income countries have been unable to scale up domestic health budgets to compensate for shrinking aid.

Inside the agency, the incoming Director-General will inherit an institution undergoing its most severe structural downsizing in decades. Following the withdrawal of the United States, WHO was forced to slash its planned 2026-2027 base budget from $5.3 billion to $4.2 billion, yet it still faces an unfunded gap of up to $300 million. To absorb this shortfall, the Secretariat is eliminating over 2,300 positions – shedding roughly a quarter of its global staff – and halving headquarters departments, leaving operational capabilities stretched thin as the new leader takes charge.

At the same time, pandemic preparedness remains stymied by North-South distrust over Pathogen Access and Benefit-Sharing (PABS) negotiations. Meanwhile, climate-driven health shocks and active global armed conflicts and crises increase the risk of global health threats, while escalating superpower rivalry threatens to further politicize its technical mandate.

Campaign roadmap towards WHA80

As the confidential nomination window transitions into the public campaign phase, Member States will soon begin direct evaluations of all prospective candidates.

The WHO Secretariat will open a password-protected web forum in November 2026, allowing Member States to submit written questions to candidates. The first live, interactive Candidates’ Forum will convene in Geneva starting 18 November 2026, providing a public platform for nominees to present their visions.

Following these presentations, the 34-member Executive Board will gather at its 160th session in January 2027 to shortlist and nominate up to three finalists. The final appointment will occur via secret ballot during the Eightieth World Health Assembly (WHA80) in May 2027, with the new Director-General taking office on 16 August 2027.

Until the Secretariat officially unveils the sealed filings in November, the full extent of the candidate field remains hidden behind the procedural curtain.

The Digital Campaigns Shaping Candidates’ Messages in Race for WHO Director-General

Image Credits: HPW, WHO/Christopher Black , LinkedIn/HPW, WHO/HPW, Kementerian Kesehatan, WHO, World Health Organization, Concordia/HPW.